Group 1 - The core issue is that Jinsong New Material has been investigated by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, which adds uncertainty to its already challenging future prospects [1][3][5] - Jinsong New Material has reported net profit losses for three consecutive years, with a significant impact on its financial health due to the ongoing investigation [2][10] - The company has stated that it will cooperate with the CSRC during the investigation and that its normal production and operations will not be significantly affected [5] Group 2 - Financial performance has been declining, with a reported revenue of 243 million yuan in 2022, down 17.19% year-on-year, and a net loss of approximately 22.51 million yuan, a staggering drop of 312.62% [10] - In 2023, revenue slightly increased to 260 million yuan, a 7.04% growth, but net losses expanded to about 23.87 million yuan, a 6.07% increase in losses compared to the previous year [10][11] - For 2024, revenue grew significantly by 28.15% to 333 million yuan, yet the net loss remained substantial at approximately 22.65 million yuan, accumulating losses exceeding 69 million yuan over three years [10][11] - The company attributes the revenue growth to a recovery in the domestic and international cosmetics market, but rising management costs and asset impairment provisions have contributed to ongoing net losses [12]

Core Viewpoint - The upcoming week will see a total of 68 stocks facing a lock-up expiration, with a combined market value of 81.671 billion yuan [3]. Group 1: Company Announcements - Jinsong New Materials (300849) received a notice from the China Securities Regulatory Commission regarding an investigation for suspected violations of information disclosure laws [1]. - The company reported a revenue of 74.43 million yuan in Q1, a year-on-year increase of 10.97%, but incurred a net loss of 3.836 million yuan [1]. Group 2: Lock-up Expiration Details - Next week, 68 stocks will have a total lock-up expiration value of 81.671 billion yuan, calculated based on the latest closing prices [3]. - Zhong Wulun Drone will have 403 million shares released, with a lock-up value of 20.02 billion yuan [4]. - Dize Pharmaceutical-U will have 223 million shares released, with a lock-up value of 13.272 billion yuan [5]. Group 3: Performance of Stocks Facing Expiration - Among the 68 stocks, 18 reported losses in Q1, with Dize Pharmaceutical-U showing the largest loss of 193 million yuan [9]. - The average stock price of the stocks facing expiration has increased by 5.08% since June [8]. - Notable gainers include Jida Zhengyuan, Jinyinhai, and Aikesibo, each with over 30% price increases [8]. Group 4: Institutional Research - Ten stocks, including Zhong Keshuguang and Dema Technology, received research attention from over five institutions in June [9]. - Zhong Keshuguang was researched by 145 institutions, focusing on a strategic restructuring involving high-end processors [9]. - Dema Technology's global smart logistics business has seen significant breakthroughs in South America this year [9].

Group 1 - The State Council, led by Li Qiang, held a meeting to discuss the implementation of the national science and technology conference spirit to accelerate the construction of a strong technology nation [1] - The central bank aims to enhance support for technological innovation and boost consumption while exploring institutional arrangements to maintain capital market stability [2] - The Shanghai and Shenzhen stock exchanges announced an adjustment of the price fluctuation limit for risk-warning stocks on the main board from 5% to 10% [3] Group 2 - Xiaomi's official account reported that within 18 hours of opening sales, the Xiaomi YU7 has surpassed 240,000 units in locked orders [4] - The domestically produced GLP-1 weight loss drug, Masitide, has been approved for long-term weight control in adults with obesity or overweight [5] - Tianfeng Securities noted that the company's price-to-book ratio is higher than the industry median [6] - Aijian Group, which has seen three consecutive trading limit increases, stated that it has not engaged in any stablecoin-related business [6] - Times Wan Heng, which has seen two consecutive trading limit increases, focuses on the research, production, and sales of new energy batteries [6] - Jinsong New Materials is under investigation by the China Securities Regulatory Commission for suspected violations of information disclosure laws [6]

Core Viewpoint - Jinsheng New Materials is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, which may impact its operations and reputation in the market [2][4]. Company Overview - Jinsheng New Materials specializes in the research, production, and sales of plastic packaging containers for cosmetics, offering over 1,000 product specifications to well-known brands such as Estée Lauder, Oushiman, and Shanghai Jahwa [4]. - The company was officially listed on the Shenzhen Stock Exchange's Growth Enterprise Market on July 10, 2020 [4]. Financial Performance - The company's financial performance has deteriorated significantly since its second year post-listing, transitioning from profit to loss starting in 2022. Although there was a slight increase in net profit in 2024, the company remains in a net loss position [4]. - The cumulative losses over the past three years exceed 69 million yuan [5]. - As of March 31, 2025, the total operating revenue was approximately 744.34 million yuan, reflecting a year-on-year increase of 10.97% [5]. - The total operating costs were approximately 770.59 million yuan, leading to an operating loss of approximately 39.90 million yuan [5]. - The net profit for the same period was approximately -38.36 million yuan, marking a year-on-year decrease of 290.10% [5]. Market Position - As of June 27, 2025, Jinsheng New Materials' stock closed at 16.48 yuan per share, with a total market capitalization of 2.5 billion yuan [5].

Group 1 - The company, Jinsong New Materials (300849), received a notice from the China Securities Regulatory Commission (CSRC) on June 27, 2025, regarding a formal investigation due to suspected violations of information disclosure laws [1] - The CSRC has decided to initiate a case against the company, indicating serious regulatory scrutiny [1] - During the investigation period, the company will actively cooperate with the CSRC while maintaining normal operations across all business activities [1]

锦盛新材：因涉嫌信息披露违法违规 遭中国证监会立案调查 智通财经6月27日电，锦盛新材(300849.SZ)公告称，公司于2025年6月27日收到中国证监会下发的《立 案告知书》，因公司涉嫌信息披露违法违规，中国证监会决定对公司立案。目前，公司各项生产经营活 动均正常开展，上述事项不会对公司的正常生产经营活动产生重大影响。 ...

本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 证券代码：300849 证券简称：锦盛新材 公告编号：2025-022 浙江锦盛新材料股份有限公司 关于收到中国证券监督管理委员会立案告知书的公告 特此公告。 浙江锦盛新材料股份有限公司 董事会 2025 年 6 月 27 日 浙江锦盛新材料股份有限公司（以下简称"公司"）于 2025 年 6 月 27 日收 到中国证券监督管理委员会（以下简称"中国证监会"）下发的《立案告知书》 （编号：证监立案字 01120250021 号），因公司涉嫌信息披露违法违规，根据《中 华人民共和国证券法》《中华人民共和国行政处罚法》等法律法规，中国证监会 决定对公司立案。 立案调查期间，公司将积极配合中国证监会的各项工作，严格按照相关规定 及监管要求履行信息披露义务。目前，公司各项生产经营活动均正常开展，上述 事项不会对公司的正常生产经营活动产生重大影响。 公司指定的信息披露媒体为《证券时报》《中国证券报》《上海证券报》和 巨潮资讯网（www.cninfo.com.cn），公司所有信息均以在上述指定媒体披露的公 告为准。敬请广大投 ...

Financial Performance Summary - In 2024, the company achieved operating revenue of 333.00 million yuan, a year-on-year increase of 28.15% compared to 259.86 million yuan in 2023 [2] - The net profit attributable to shareholders was -22.65 million yuan, improving by 5.14% from -23.87 million yuan in the previous year [2] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -31.88 million yuan, a decrease of 2.79% from -32.79 million yuan in 2023 [2] - The net cash flow from operating activities was 42.71 million yuan, showing a significant increase of 112.01% from 20.14 million yuan in the previous year [2] Q1 2025 Performance - For the first quarter of 2025, the company reported operating revenue of 7.44 million yuan, a year-on-year growth of 10.97% compared to 6.71 million yuan in the same period last year [3] - The net profit attributable to shareholders was -0.38 million yuan, worsening from -0.10 million yuan in the previous year [3] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -0.47 million yuan, compared to -0.32 million yuan in the same period last year, reflecting a decline of 47.79% [3] - The net cash flow from operating activities was -2.67 million yuan, a significant decrease from 0.32 million yuan in the previous year [3] Company Background - The company was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on July 10, 2020, with an initial public offering of 25 million shares at a price of 13.99 yuan per share [4] - The total amount raised was 350 million yuan, with a net amount of 293 million yuan allocated for production capacity expansion projects [4]

证券代码：300849 证券简称：锦盛新材 公告编号：2025-021 浙江锦盛新材料股份有限公司 2024 年度股东大会决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、 本次股东大会没有出现否决议案的情况； 2、 本次股东大会不涉及变更以往股东大会已通过决议的情况。 一、 会议召开和出席情况 （一） 会议召开情况 1、会议召开时间： (1) 现场会议召开时间：2025年5月22日（星期四）下午14:30 (2) 网络投票时间：通过深圳证券交易所交易系统进行网络投票的具体时间 为：2025年5月22日上午9:15-9:25，9:30-11:30，下午13:00-15:00；通过深圳证券 交易所互联网投票系统投票的具体时间为：2025年5月22日9:15-15:00期间的任意 时间。 2、会议召开方式：本次股东大会采取现场投票与网络投票相结合的方式。 3、会议召开地点：浙江省绍兴市越城区沥海街道渔舟路9号办公楼1楼会议 室。 4、会议召集人：公司董事会。 5、会议主持人：公司董事长阮荣涛先生 6、本次会议的召集、召开符合有关法律、行政法 ...

上海市锦天城律师事务所 关于浙江锦盛新材料股份有限公司 2024 年度股东大会的 法律意见书 地址：上海市浦东新区银城中路 501 号上海中心大厦 9/11/12 层 电话：021-20511000 传真：021-20511999 邮编：200120 上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 关于浙江锦盛新材料股份有限公司 2024 年度股东大会的 法律意见书 致：浙江锦盛新材料股份有限公司 上海市锦天城律师事务所（以下简称"本所"）接受浙江锦盛新材料股份有限 公司（以下简称"公司"）委托，就公司召开 2024 年度股东大会（以下简称"本次 股东大会"）的有关事宜，根据《中华人民共和国公司法》（以下简称《公司法》）、 《上市公司股东会规则》等法律、法规、规章和其他规范性文件以及《浙江锦盛 新材料股份有限公司章程》（以下简称《公司章程》）的有关规定，出具本法律意 见书。 为出具本法律意见书，本所律师对本次股东大会所涉及的相关事项进行了必 要的核查和验证，审查了本所律师认为出具该法律意见书所需审查的相关文件、 资料，并参加了公司本次股东大会现场会议的全过程。 鉴此，本所律师根据上述法律、法规、规 ...